FDA Inspection 746821 — Piedmont Reproductive Endocrinology Group, PA
The FDA completed an inspection of Piedmont Reproductive Endocrinology Group, PA on Sep 27, 2011 in Asheville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 27, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Asheville, NC (United States)